GDUFA III May Be Opportunity For Proactive Pharmacovigilance Discussions

 
• By Derrick Gingery
Blister Packs
FDA and sponsors may be interested in increasing communications related to generic drug pharmacovigilance activities. • Source: Shutterstock

More from Post-Marketing Regulation & Studies

More from Product Reviews